𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma

✍ Scribed by Sydney Ch'ng; Irene Low; Daniel Ng; Helen Brasch; Michael Sullivan; Paul Davis; Swee T. Tan

Book ID
116534416
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
326 KB
Volume
39
Category
Article
ISSN
1532-8392

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Epidermal growth factor receptor targete
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR

Radiolabeled cetuximab: Dose optimizatio
Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
✍ Bianca A.W. Hoeben; Janneke D.M. Molkenboer-Kuenen; Wim J.G. Oyen; Wenny J.M. Pe πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 563 KB

## Abstract Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head‐and‐neck squamous cell carcinoma could be of value to select patients for EGFR‐targeted therapy. We assessed dose optimization of ^111^Indium‐DTPA‐cetuximab (^111^In‐cetuximab) for EGFR imaging in a head‐and‐neck